---
title: "Apog appoints resignations of Andrew Gottesdiener and Peter Harwin from board"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/284051243.md"
description: "Apog announced the resignations of Andrew Gottesdiener, M.D. and Peter Harwin from its board, effective May 11, 2026. The resignations are not due to any disagreements with the company regarding its operations, policies, or practices. Replacement information has not been disclosed. This announcement was filed with the SEC as part of Apogee Therapeutics, Inc.'s 8-K on April 24, 2026."
datetime: "2026-04-24T20:23:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/284051243.md)
  - [en](https://longbridge.com/en/news/284051243.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/284051243.md)
---

# Apog appoints resignations of Andrew Gottesdiener and Peter Harwin from board

**Apog announced that Andrew Gottesdiener, M.D. and Peter Harwin will resign from the board effective May 11, 2026.**

Individual

Andrew Gottesdiener, M.D.

Peter Harwin

Role

Director

Director

Type of Change

Resignation

Resignation

Effective Date

May 11, 2026

May 11, 2026

Reason

Not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices

Not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices

Replacement Info

Not disclosed

Not disclosed

Background Details

Not disclosed

Not disclosed

Board/Committee Role Changes

Not disclosed

Not disclosed

Original SEC Filing: Apogee Therapeutics, Inc. \[ APGE \] - 8-K - Apr. 24, 2026

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [APGE.US](https://longbridge.com/en/quote/APGE.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)

## Related News & Research

- [BeOne Medicines Sets the Pace in Oncology at ASCO and EHA 2026 with 60+ Abstracts | ONC Stock News](https://longbridge.com/en/news/287198763.md)
- [Roivant posts unexpected Q4 profit due to Moderna lawsuit settlement gain](https://longbridge.com/en/news/287053604.md)
- [Wave Life Sciences posts positive RestorAATion-2 data; WVE-006 restores M-AAT, cuts Z-AAT, supports monthly dosing](https://longbridge.com/en/news/286818220.md)
- [Capricor publishes investor presentation on deramiocel Duchenne muscular dystrophy program](https://longbridge.com/en/news/287222906.md)
- [ImmunityBio Expands Bladder Cancer Arsenal With Exclusive Japanese BCG Partnership](https://longbridge.com/en/news/286787574.md)